Daniel J. O'Connor - 05 Jan 2023 Form 4 Insider Report for SEELOS THERAPEUTICS, INC.

Role: Director
Signature: /s/ Michael Golembiewski, as attorney-in-fact for Daniel J. O'Connor
Issuer symbol: N/A
Transactions as of: 05 Jan 2023
Net transactions value: $0
Form type: 4
Filing time: 05 Jan 2023, 18:20:04 UTC
Previous filing: 03 Jan 2023
Next filing: 28 Apr 2023
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	SEEL	Stock Option (right to buy)	Award	$0	+50,000		$0.000000	50,000	05 Jan 2023	Common Stock	50,000	$0.8100	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	1/12th of the shares subject to the option shall vest on February 5, 2023, and 1/12th of the shares subject to the option shall vest monthly thereafter.